首页 > 最新文献

Journal of Basic and Clinical Pharmacy最新文献

英文 中文
Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile 瑞舒伐他汀单独或联合Omega-3脂肪酸对脂联素水平和心脏代谢谱的影响
Pub Date : 2016-12-01 DOI: 10.4103/0976-0105.195080
H. Al-kuraishy, Ali I. Al-Gareeb
Background: Adiponectin is an important adipocyte-related protein that has been postulated to participate in prevention of the development of metabolic syndrome. The relationship between adiponectin serum levels and risk of coronary artery disease (CAD) has been widely investigated and remains controversial. The aim of the present study was to evaluate the effects of rosuvastatin and/or omega-3 fatty acid on adiponectin serum levels in patients with insulin resistance (IR) and CAD. Patients and Methods: This study involved 87 patients with CADs and IR of different etiology, the patients were divided into three groups; 24 patients on treatment with rosuvastatin, 22 patients on treatment with omega-3 fatty acid, 23 patients on treatment with omega-3 fatty acid and rosuvastatin, 18 patients were not previously or currently treated with either rosuvastatin or omega-3 fatty acid, those regarded as control patients. Anthropometric measures, adiponectin serum levels, and other biochemical parameters were assessed in each treated group. Results: Rosuvastatin therapy leads to a significant elevation in adiponectin serum levels from 4.1 ± 0.99 ng/mL to 6.76 ± 1.03 ng/mL compared to control P < 0.01. Omega-3 fatty acid therapy leads to a significant elevation in adiponectin serum levels from 4.1 ± 0.99 ng/mL to 6.11 ± 1.29 ng/mL compared to control P < 0.01. Rosuvastatin plus omega-3 fatty acid therapy lead to a significant elevation in adiponectin serum levels from 4.1 ± 0.99 ng/mL to 7.99 ± 1.76 ng/mL compared to control P < 0.01. Conclusions: Rosuvastatin and/or omega-3 fatty acid lead to significant cardiometabolic protection through an increment in adiponectin serum levels.
背景:脂联素是一种重要的脂肪细胞相关蛋白,被认为参与预防代谢综合征的发生。脂联素血清水平与冠状动脉疾病(CAD)风险之间的关系已被广泛研究,但仍存在争议。本研究的目的是评估瑞舒伐他汀和/或omega-3脂肪酸对胰岛素抵抗(IR)和CAD患者血清脂联素水平的影响。患者与方法:本研究纳入87例不同病因的CADs合并IR患者,将患者分为3组;瑞舒伐他汀治疗24例,欧米伽-3脂肪酸治疗22例,欧米伽-3脂肪酸联合瑞舒伐他汀治疗23例,既往或目前未接受瑞舒伐他汀或欧米伽-3脂肪酸治疗的18例,作为对照组。对每个治疗组的人体测量、血清脂联素水平和其他生化参数进行评估。结果:瑞舒伐他汀治疗组血清脂联素水平由4.1±0.99 ng/mL显著升高至6.76±1.03 ng/mL, P < 0.01。与对照组相比,Omega-3脂肪酸治疗导致血清脂联素水平从4.1±0.99 ng/mL显著升高至6.11±1.29 ng/mL, P < 0.01。瑞舒伐他汀加omega-3脂肪酸治疗导致血清脂联素水平从4.1±0.99 ng/mL显著升高到7.99±1.76 ng/mL,与对照组相比P < 0.01。结论:瑞舒伐他汀和/或omega-3脂肪酸通过增加血清脂联素水平而产生显著的心脏代谢保护作用。
{"title":"Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile","authors":"H. Al-kuraishy, Ali I. Al-Gareeb","doi":"10.4103/0976-0105.195080","DOIUrl":"https://doi.org/10.4103/0976-0105.195080","url":null,"abstract":"Background: Adiponectin is an important adipocyte-related protein that has been postulated to participate in prevention of the development of metabolic syndrome. The relationship between adiponectin serum levels and risk of coronary artery disease (CAD) has been widely investigated and remains controversial. The aim of the present study was to evaluate the effects of rosuvastatin and/or omega-3 fatty acid on adiponectin serum levels in patients with insulin resistance (IR) and CAD. Patients and Methods: This study involved 87 patients with CADs and IR of different etiology, the patients were divided into three groups; 24 patients on treatment with rosuvastatin, 22 patients on treatment with omega-3 fatty acid, 23 patients on treatment with omega-3 fatty acid and rosuvastatin, 18 patients were not previously or currently treated with either rosuvastatin or omega-3 fatty acid, those regarded as control patients. Anthropometric measures, adiponectin serum levels, and other biochemical parameters were assessed in each treated group. Results: Rosuvastatin therapy leads to a significant elevation in adiponectin serum levels from 4.1 ± 0.99 ng/mL to 6.76 ± 1.03 ng/mL compared to control P < 0.01. Omega-3 fatty acid therapy leads to a significant elevation in adiponectin serum levels from 4.1 ± 0.99 ng/mL to 6.11 ± 1.29 ng/mL compared to control P < 0.01. Rosuvastatin plus omega-3 fatty acid therapy lead to a significant elevation in adiponectin serum levels from 4.1 ± 0.99 ng/mL to 7.99 ± 1.76 ng/mL compared to control P < 0.01. Conclusions: Rosuvastatin and/or omega-3 fatty acid lead to significant cardiometabolic protection through an increment in adiponectin serum levels.","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"20 1","pages":"8 - 14"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87348994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 29
Antiepileptic Drugs-induced Stevens–Johnson syndrome: A case Series 抗癫痫药物诱导的史蒂文斯-约翰逊综合征:一个病例系列
Pub Date : 2016-12-01 DOI: 10.4103/0976-0105.195130
B. Trivedi, N. Darji, S. Malhotra, Pankaj R. Patel
Stevens-Johnson syndrome (SJS) is an acute life-threatening mucocutaneous reaction, characterized by extensive necrosis and detachment of the epidermis from the skin. The overall incidence of SJS is seen in five cases per million people per year. SJS is typically caused by drugs and is a kind of idiosyncratic reaction. Adverse drug reactions such an SJS have a remarkable effect on patient′s safety issues. We encountered nine cases of antiepileptic drug (AED)-induced SJS, specifically with carbamazepine, oxcarbazepine, and phenytoin. To manage the reaction, the clinician withdrew the drug in all 8 cases, and in 1 case, the patient was shifted to valproate and symptomatic treatment was provided. There is still a controversy whether or not all AEDs can cause SJS. Recent studies have investigated the role of genetic factors - HLABFNx011502 allele in the development of AED-induced SJS in patients of Asian ancestry.
史蒂文斯-约翰逊综合征(SJS)是一种急性危及生命的皮肤粘膜反应,其特征是广泛坏死和表皮脱离皮肤。SJS的总发病率为每年每百万人中有5例。SJS通常是由药物引起的,是一种特殊反应。SJS等药物不良反应对患者的安全问题影响显著。我们遇到了9例抗癫痫药物(AED)诱导的SJS,特别是卡马西平、奥卡西平和苯妥英。为控制反应,8例患者均被临床医生停药,其中1例患者改用丙戊酸钠对症治疗。是否所有的aed都能引起SJS仍然存在争议。最近的研究调查了遗传因素HLABFNx011502等位基因在aed诱导的亚洲患者SJS发生中的作用。
{"title":"Antiepileptic Drugs-induced Stevens–Johnson syndrome: A case Series","authors":"B. Trivedi, N. Darji, S. Malhotra, Pankaj R. Patel","doi":"10.4103/0976-0105.195130","DOIUrl":"https://doi.org/10.4103/0976-0105.195130","url":null,"abstract":"Stevens-Johnson syndrome (SJS) is an acute life-threatening mucocutaneous reaction, characterized by extensive necrosis and detachment of the epidermis from the skin. The overall incidence of SJS is seen in five cases per million people per year. SJS is typically caused by drugs and is a kind of idiosyncratic reaction. Adverse drug reactions such an SJS have a remarkable effect on patient′s safety issues. We encountered nine cases of antiepileptic drug (AED)-induced SJS, specifically with carbamazepine, oxcarbazepine, and phenytoin. To manage the reaction, the clinician withdrew the drug in all 8 cases, and in 1 case, the patient was shifted to valproate and symptomatic treatment was provided. There is still a controversy whether or not all AEDs can cause SJS. Recent studies have investigated the role of genetic factors - HLABFNx011502 allele in the development of AED-induced SJS in patients of Asian ancestry.","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"1 1","pages":"42 - 44"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89802119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Rare Manifestation of Digoxin Toxicity: Right Bundle Branch Block 地高辛毒性的罕见表现:右束支阻滞
Pub Date : 2016-12-01 DOI: 10.4103/0976-0105.195128
D. Gill, S. Zaidi
A 76-year-old female, with medical history significant for systolic congestive heart failure, who presented to the emergency department with lethargy and abdominal pain with diarrhea for the past 3 weeks. Due to hypotension, the patient received multiple boluses of isotonic saline and was started on norepinephrine. Laboratories were significant for severe digoxin toxicity (29 ng/mL), in setting of acute kidney injury. Electrocardiogram (EKG) revealed a new right bundle branch block (RBBB). She was given Digibind and her repeat digoxin level was 20 ng/mL. Repeat EKG showed resolved RBBB. This case identifies that patients with digoxin toxicity are at risk for RBBB. This is a rare finding and is not commonly recognized. Emergency medicine physicians are often the first to encounter patients with digoxin toxicity and need to be aware of such EKG findings.
76岁女性,既往有明显收缩期充血性心力衰竭病史,过去3周以昏睡、腹痛并腹泻就诊于急诊科。由于低血压,患者接受了多次等渗生理盐水,并开始使用去甲肾上腺素。在急性肾损伤的情况下,实验室对地高辛的严重毒性(29 ng/mL)具有显著意义。心电图显示新的右束支传导阻滞(RBBB)。给予地高辛,重复地高辛浓度为20 ng/mL。重复心电图显示RBBB溶解。本病例表明地高辛毒性患者有发生RBBB的风险。这是一种罕见的发现,不被普遍认识。急诊医师通常是第一个遇到地高辛中毒的患者,他们需要了解这样的心电图结果。
{"title":"Rare Manifestation of Digoxin Toxicity: Right Bundle Branch Block","authors":"D. Gill, S. Zaidi","doi":"10.4103/0976-0105.195128","DOIUrl":"https://doi.org/10.4103/0976-0105.195128","url":null,"abstract":"A 76-year-old female, with medical history significant for systolic congestive heart failure, who presented to the emergency department with lethargy and abdominal pain with diarrhea for the past 3 weeks. Due to hypotension, the patient received multiple boluses of isotonic saline and was started on norepinephrine. Laboratories were significant for severe digoxin toxicity (29 ng/mL), in setting of acute kidney injury. Electrocardiogram (EKG) revealed a new right bundle branch block (RBBB). She was given Digibind and her repeat digoxin level was 20 ng/mL. Repeat EKG showed resolved RBBB. This case identifies that patients with digoxin toxicity are at risk for RBBB. This is a rare finding and is not commonly recognized. Emergency medicine physicians are often the first to encounter patients with digoxin toxicity and need to be aware of such EKG findings.","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"22 1","pages":"40 - 41"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85670401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prevalence of potentially inappropriate medications and prescription cost analysis among older cardiac patients in an outpatient department of a tertiary care hospital in India 印度某三级医院门诊部老年心脏病患者中潜在不适当药物的流行程度和处方成本分析
Pub Date : 2016-07-01 DOI: 10.4103/0976-0105.189434
K. Shah, Harshdeep Joshi, R. P. Christian, K. Patel, S. Malhotra
Aims: The aim of this study is to evaluate potentially inappropriate medications (PIMs) in the elderly at cardiology outpatient department (OPD) of a tertiary care teaching hospital using Beers criteria and to find the direct cost burden of PIMs. Materials and Methods: The present study was an observational cross-sectional study. Prescriptions of the patients′ aged ≥65 years were collected from the cardiology OPD and were analyzed. PIMs were identified with the help of Beers 2012 criteria. Direct costs of prescribed drugs were calculated. Predictors (comorbid conditions, number of drugs prescribed) associated with PIM use were identified using bivariate analysis. Multivariate logistic regression was then applied to study the influence of these variables on PIM use. A P < 0.05 was considered statistically significant. Results: A total of 236 patients received 1443 drugs. According to Beers 2012 criteria, 29.3% patients received at least one PIM followed by two and three PIMs in 10 and 23 patients, respectively. The most commonly prescribed PIM was spironolactone in 15.7% patients followed by benzodiazepines in 15 patients. The total cost of therapy for 1 day was Indian Rupee (INR) 10,029.2 while total cost of all prescribed medications in per day was INR 42.5. Conclusions: This study showed higher use of PIMs among the elderly in cardiac OPD. It is important to improve the situation of older cardiac patients who have higher use of PIMs. In older patients, high prevalence of PIMs was associated with increased cost. The use of regular continuing medical education program by the hospital and educating and training doctors on rational prescribing will help alleviate this issue.
目的:本研究的目的是利用Beers标准评估三级护理教学医院心脏病门诊(OPD)老年人的潜在不适当药物(PIMs),并找出PIMs的直接成本负担。材料与方法:本研究为观察性横断面研究。收集年龄≥65岁的心内科门诊患者的处方进行分析。pim是在Beers 2012标准的帮助下确定的。计算处方药的直接成本。使用双变量分析确定与PIM使用相关的预测因素(合并症、处方药物数量)。然后应用多元逻辑回归研究这些变量对PIM使用的影响。P < 0.05为差异有统计学意义。结果:236例患者共使用1443种药物。根据Beers 2012的标准,29.3%的患者分别在10例和23例患者中接受了至少一次PIM,其次是两次和三次PIM。最常用的PIM是螺内酯(15.7%),其次是苯二氮卓类(15例)。治疗1天的总费用为10029.2印度卢比(INR),而每天所有处方药的总费用为42.5印度卢比。结论:本研究显示老年心内科急症患者使用pim的比例较高。重要的是要改善老年心脏病患者的情况,他们使用较多的pim。在老年患者中,pim的高流行率与费用增加有关。医院定期开展继续医学教育项目,对医生进行合理开药的教育和培训,将有助于缓解这一问题。
{"title":"Prevalence of potentially inappropriate medications and prescription cost analysis among older cardiac patients in an outpatient department of a tertiary care hospital in India","authors":"K. Shah, Harshdeep Joshi, R. P. Christian, K. Patel, S. Malhotra","doi":"10.4103/0976-0105.189434","DOIUrl":"https://doi.org/10.4103/0976-0105.189434","url":null,"abstract":"Aims: The aim of this study is to evaluate potentially inappropriate medications (PIMs) in the elderly at cardiology outpatient department (OPD) of a tertiary care teaching hospital using Beers criteria and to find the direct cost burden of PIMs. Materials and Methods: The present study was an observational cross-sectional study. Prescriptions of the patients′ aged ≥65 years were collected from the cardiology OPD and were analyzed. PIMs were identified with the help of Beers 2012 criteria. Direct costs of prescribed drugs were calculated. Predictors (comorbid conditions, number of drugs prescribed) associated with PIM use were identified using bivariate analysis. Multivariate logistic regression was then applied to study the influence of these variables on PIM use. A P < 0.05 was considered statistically significant. Results: A total of 236 patients received 1443 drugs. According to Beers 2012 criteria, 29.3% patients received at least one PIM followed by two and three PIMs in 10 and 23 patients, respectively. The most commonly prescribed PIM was spironolactone in 15.7% patients followed by benzodiazepines in 15 patients. The total cost of therapy for 1 day was Indian Rupee (INR) 10,029.2 while total cost of all prescribed medications in per day was INR 42.5. Conclusions: This study showed higher use of PIMs among the elderly in cardiac OPD. It is important to improve the situation of older cardiac patients who have higher use of PIMs. In older patients, high prevalence of PIMs was associated with increased cost. The use of regular continuing medical education program by the hospital and educating and training doctors on rational prescribing will help alleviate this issue.","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"54 1","pages":"110 - 115"},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72795601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Carbamazepine-induced angioedema Carbamazepine-induced血管性水肿
Pub Date : 2016-07-01 DOI: 10.4103/0976-0105.189436
Ansha Subramanian, M. Adhimoolam, S. Gopalakrishnan, Meher Ali Rajamohammed
Angioedema is a rare adverse reaction of carbamazepine, which causes localized tissue edema in submucosal and subcutaneous tissue mediated by histamine, serotonin, and kinins (bradykinin). We report a case of 34-year-old female who developed angioedema, 24 h after administration of carbamazepine for treating bipolar disorder. Patient′s symptoms responded rapidly with antihistamine therapy and with the withdrawal of carbamazepine, the offending drug. Carbamazepine-induced angioedema is a life-threatening reaction which requires immediate treatment and monitoring in order to avoid morbidity and mortality.
血管性水肿是卡马西平的一种罕见不良反应,可引起黏膜下和皮下组织局部水肿,由组胺、5 -羟色胺和激肽(缓激肽)介导。我们报告了一例34岁的女性,在卡马西平治疗双相情感障碍24小时后出现血管性水肿。病人的症状在抗组胺治疗和停用卡马西平后反应迅速。卡马西平引起的血管性水肿是一种危及生命的反应,需要立即治疗和监测,以避免发病率和死亡率。
{"title":"Carbamazepine-induced angioedema","authors":"Ansha Subramanian, M. Adhimoolam, S. Gopalakrishnan, Meher Ali Rajamohammed","doi":"10.4103/0976-0105.189436","DOIUrl":"https://doi.org/10.4103/0976-0105.189436","url":null,"abstract":"Angioedema is a rare adverse reaction of carbamazepine, which causes localized tissue edema in submucosal and subcutaneous tissue mediated by histamine, serotonin, and kinins (bradykinin). We report a case of 34-year-old female who developed angioedema, 24 h after administration of carbamazepine for treating bipolar disorder. Patient′s symptoms responded rapidly with antihistamine therapy and with the withdrawal of carbamazepine, the offending drug. Carbamazepine-induced angioedema is a life-threatening reaction which requires immediate treatment and monitoring in order to avoid morbidity and mortality.","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"45 1","pages":"120 - 122"},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82882970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of anxiolytic effects of aripiprazole and hydroxyzine as a combination in mice 阿立哌唑与羟嗪联用对小鼠抗焦虑作用的评价
Pub Date : 2016-07-01 DOI: 10.4103/0976-0105.189429
Nikita Shekhar Sawantdesai, P. Kale, J. Savai
Context: Anxiety disorders are chronic, common, and often comorbid. There is an unmet need in its treatment. Aripiprazole and hydroxyzine are well-known therapeutic options used as monotherapy in clinics. They have different mechanisms and site of actions. Aim: The objective of the present study was to evaluate the anxiolytic effect of aripiprazole and hydroxyzine in combination. Materials and Methods: Swiss albino mice (male) received treatment of 5% of Tween 80 in 0.9% saline (10 ml/kg; control group), "aripiprazole alone" (1 mg/kg), "hydroxyzine alone" (3 mg/kg), and aripiprazole (0.5 mg/kg) + hydroxyzine (1.5 mg/kg) through the intraperitoneal route. Statistical Analysis Used: One-way ANOVA followed by Tukey′s honest significant difference was employed for statistical analysis. Results: The in vivo outcomes (elevated plus maze, light/dark transition, and marble burying tests) of hydroxyzine monotherapy-treated group showed a significant anxiolytic activity. The combination-treated group was found to be better than control and aripiprazole-treated groups. The combination-treated group showed a significant increase in the level of serotonin in different brain regions as compared to aripiprazole-treated group but not better than the hydroxyzine group. The in vitro results were in compliance with the in vivo results. The combinational approach was found to be beneficial in anxiolytic treatment as compared to aripiprazole monotherapy. However, hydroxyzine showed better anxiolytic activity when compared to control, aripiprazole monotherapy, and combination groups. Conclusions: The anxiolytic effect of combination-treated group was found to be better than aripiprazole monotherapy and lesser than hydroxyzine monotherapy.
背景:焦虑障碍是慢性的,常见的,并且经常是合并症。在治疗上有一个未被满足的需求。阿立哌唑和羟嗪是临床上常用的单一疗法。它们有不同的机制和作用部位。目的:评价阿立哌唑与羟嗪合用的抗焦虑作用。材料与方法:瑞士白化病小鼠(雄性)给予5% Tween 80 0.9%生理盐水(10 ml/kg;对照组)、“阿立哌唑单用”(1mg /kg)、“羟嗪单用”(3mg /kg)、阿立哌唑(0.5 mg/kg) +羟嗪(1.5 mg/kg)腹腔注射。统计分析方法:采用单因素方差分析和Tukey 's诚实显著差异进行统计分析。结果:羟嗪单药组的体内指标(升高加迷宫、明暗转换和大理石掩埋试验)显示出显著的抗焦虑活性。联合治疗组疗效优于对照组和阿立哌唑治疗组。与阿立哌唑治疗组相比,联合治疗组各脑区血清素水平显著升高,但不优于羟嗪治疗组。体外实验结果与体内实验结果一致。与阿立哌唑单药治疗相比,联合治疗在抗焦虑治疗中是有益的。然而,与对照组、阿立哌唑单药组和联合组相比,羟嗪表现出更好的抗焦虑活性。结论:联合治疗组抗焦虑效果优于阿立哌唑单药,优于羟嗪单药。
{"title":"Evaluation of anxiolytic effects of aripiprazole and hydroxyzine as a combination in mice","authors":"Nikita Shekhar Sawantdesai, P. Kale, J. Savai","doi":"10.4103/0976-0105.189429","DOIUrl":"https://doi.org/10.4103/0976-0105.189429","url":null,"abstract":"Context: Anxiety disorders are chronic, common, and often comorbid. There is an unmet need in its treatment. Aripiprazole and hydroxyzine are well-known therapeutic options used as monotherapy in clinics. They have different mechanisms and site of actions. Aim: The objective of the present study was to evaluate the anxiolytic effect of aripiprazole and hydroxyzine in combination. Materials and Methods: Swiss albino mice (male) received treatment of 5% of Tween 80 in 0.9% saline (10 ml/kg; control group), \"aripiprazole alone\" (1 mg/kg), \"hydroxyzine alone\" (3 mg/kg), and aripiprazole (0.5 mg/kg) + hydroxyzine (1.5 mg/kg) through the intraperitoneal route. Statistical Analysis Used: One-way ANOVA followed by Tukey′s honest significant difference was employed for statistical analysis. Results: The in vivo outcomes (elevated plus maze, light/dark transition, and marble burying tests) of hydroxyzine monotherapy-treated group showed a significant anxiolytic activity. The combination-treated group was found to be better than control and aripiprazole-treated groups. The combination-treated group showed a significant increase in the level of serotonin in different brain regions as compared to aripiprazole-treated group but not better than the hydroxyzine group. The in vitro results were in compliance with the in vivo results. The combinational approach was found to be beneficial in anxiolytic treatment as compared to aripiprazole monotherapy. However, hydroxyzine showed better anxiolytic activity when compared to control, aripiprazole monotherapy, and combination groups. Conclusions: The anxiolytic effect of combination-treated group was found to be better than aripiprazole monotherapy and lesser than hydroxyzine monotherapy.","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"27 1","pages":"97 - 104"},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88715093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Use of simulated patient approach to assess the community pharmacists’ knowledge of appropriate use of metered dose inhaler 采用模拟病人方法评估社区药师对正确使用计量吸入器的知识
Pub Date : 2016-07-01 DOI: 10.4103/0976-0105.189435
S. Nduka, M. Anetoh, K. Amorha, Okechukwu O. Henry, M. Okonta
Rationale: The pharmacist charged with the responsibility of drug administration and counseling should have the basic knowledge and skills necessary to demonstrate the use of metered dose inhalers (MDIs) to asthma patients for the maximization of treatment outcomes. Objective: This study was designed to evaluate the community pharmacists′ knowledge of the appropriate use of MDIs in Anambra State, Nigeria. Methods: The study was carried out in two major cities in Anambra State, Nigeria, using 41 registered community pharmacists. A simulated patient approach utilizing two adequately trained pharmacy students were used. Obtained data were analyzed using independent t-test and one-way ANOVA through SPSS version 18. Results: The pharmacists had a mean demonstration score of 45.45%. Step number seven of the correct use of MDI, which involves breathing in and depressing the canister was the most demonstrated step (90.2%) while step 4 which involves tilting the head back slightly was the least demonstrated (14.6%) by the pharmacists. Among five identified critical steps in asthma guideline used, two were well demonstrated (75.6% and 90.2%): one averagely demonstrated (51.2%) and two poorly demonstrated (39% and 31.7%). Sociodemographic characteristics did not influence the demonstration ability of the pharmacists in this study. Conclusion: The study indicated that community pharmacists lacked the adequate knowledge of appropriate use of MDI. Training programs for pharmacists focusing on the use of such devices will enable them to educate patients on the effective use of MDIs in patients with asthma.
理由:负责给药和咨询的药剂师应具备必要的基本知识和技能,以证明对哮喘患者使用计量吸入器(MDIs)以获得最大的治疗效果。目的:本研究旨在评估尼日利亚阿南布拉州社区药师对MDIs正确使用的了解。方法:选取尼日利亚阿南布拉州两个主要城市的41名注册社区药师进行研究。采用两名训练有素的药学学生的模拟病人方法。所得数据通过SPSS version 18采用独立t检验和单因素方差分析进行分析。结果:药师的平均示范得分为45.45%。正确使用MDI的第7步,包括吸气和压下药筒,是药剂师演示最多的步骤(90.2%),而第4步,包括轻微向后倾斜的头,是最少的(14.6%)。在使用的哮喘指南中确定的5个关键步骤中,有2个得到了很好的证明(75.6%和90.2%),1个得到了一般的证明(51.2%),2个表现不佳(39%和31.7%)。在本研究中,社会人口学特征对药师的论证能力没有影响。结论:社区药师对MDI的正确使用缺乏足够的知识。针对药剂师的培训计划侧重于使用这种装置,这将使他们能够教育哮喘患者如何有效地使用吸入吸入器。
{"title":"Use of simulated patient approach to assess the community pharmacists’ knowledge of appropriate use of metered dose inhaler","authors":"S. Nduka, M. Anetoh, K. Amorha, Okechukwu O. Henry, M. Okonta","doi":"10.4103/0976-0105.189435","DOIUrl":"https://doi.org/10.4103/0976-0105.189435","url":null,"abstract":"Rationale: The pharmacist charged with the responsibility of drug administration and counseling should have the basic knowledge and skills necessary to demonstrate the use of metered dose inhalers (MDIs) to asthma patients for the maximization of treatment outcomes. Objective: This study was designed to evaluate the community pharmacists′ knowledge of the appropriate use of MDIs in Anambra State, Nigeria. Methods: The study was carried out in two major cities in Anambra State, Nigeria, using 41 registered community pharmacists. A simulated patient approach utilizing two adequately trained pharmacy students were used. Obtained data were analyzed using independent t-test and one-way ANOVA through SPSS version 18. Results: The pharmacists had a mean demonstration score of 45.45%. Step number seven of the correct use of MDI, which involves breathing in and depressing the canister was the most demonstrated step (90.2%) while step 4 which involves tilting the head back slightly was the least demonstrated (14.6%) by the pharmacists. Among five identified critical steps in asthma guideline used, two were well demonstrated (75.6% and 90.2%): one averagely demonstrated (51.2%) and two poorly demonstrated (39% and 31.7%). Sociodemographic characteristics did not influence the demonstration ability of the pharmacists in this study. Conclusion: The study indicated that community pharmacists lacked the adequate knowledge of appropriate use of MDI. Training programs for pharmacists focusing on the use of such devices will enable them to educate patients on the effective use of MDIs in patients with asthma.","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"1 1","pages":"116 - 119"},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88131364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Antioxidant and hepatoprotective properties of Indian Sunderban mangrove Bruguiera gymnorrhiza L. leave. 印度桑德班红树榄叶的抗氧化和保肝作用。
Pub Date : 2016-06-01 DOI: 10.4103/0976-0105.183262
Tapas Kumar Sur, Avijit Hazra, Alok Kumar Hazra, Dipankar Bhattacharyya

Background: Bruguiera gymnorrhiza L. (family Rhizophoraceae) is a true mangrove habitat in Indian Sunderban and traditionally uses for liver disorders.

Objectives: The aim was to evaluate antioxidant and hepatoprotective actions of leave extract of B. gymnorrhiza L.

Materials and methods: Hydro-methanolic extract of mangrove leaves (BR) was standardized using spectrophotometric and high-performance thin layer chromatography methods. Radical scavenging activities were assessed in different in vitro methods, like 1,1-diphenyl-2-picrylhydrazyl, 2,2'-azino-bis-3-ethyl benzthiazoline-6-sulphonic acid (+), superoxides, nitric oxides and hydroxyl radicals. Hepatoprotective efficacy of BR (125 mg/kg and 250 mg/kg, p.o) was measured in D-galactosamine (GalN) induced (200 mg/kg, i.p) hepatitis in Wistar rats. Silymarin (25 mg/kg, p.o) was used as known hepatoprotective agent.

Results: Polyphenols such as gallic acid, quercetin, and coumarin obtained from BR exhibited powerful antioxidant properties. Moreover, it produced dose-dependent protection against GalN induced hepatitis in rats. It significantly reduced GalN induced elevation of enzymes (alanine transaminase, aspartate aminotransferase, and alkaline phosphatase) in serum and resist oxidative stress marked by lipid peroxides, glutathione, and catalase in hepatic parenchyma.

Conclusions: Polyphenols rich B. gymnorrhiza L. leaves ameliorate hepatic tissue injury through its antioxidant effects.

背景:木榄是一种真正的红树林栖息地在印度桑德班和传统上用于肝脏疾病。目的:评价裸子藤叶提取物的抗氧化和保肝作用。材料和方法:采用分光光度法和高效薄层色谱法对红树叶水甲醇提取物(BR)进行标准化。以1,1-二苯基-2-picrylhydrazyl、2,2'-氮基-双-3-乙基苯并噻唑-6-磺酸(+)、超氧化物、一氧化氮和羟基自由基等体外清除自由基的能力进行了研究。研究了丁胺醇(125 mg/kg和250 mg/kg, p.o)对d -半乳糖胺(GalN)诱导的Wistar大鼠肝炎(200 mg/kg, i.p)的肝保护作用。水飞蓟素(25 mg/kg, p.o)作为已知的肝保护剂。结果:BR中制备的没食子酸、槲皮素、香豆素等多酚类物质具有较强的抗氧化性能。此外,它对GalN诱导的大鼠肝炎具有剂量依赖性的保护作用。显著降低GalN诱导的血清酶(谷丙转氨酶、天冬氨酸转氨酶和碱性磷酸酶)升高,抵抗肝实质中以脂质过氧化物、谷胱甘肽和过氧化氢酶为标志的氧化应激。结论:富多酚的裸子叶通过抗氧化作用改善肝组织损伤。
{"title":"Antioxidant and hepatoprotective properties of Indian Sunderban mangrove Bruguiera gymnorrhiza L. leave.","authors":"Tapas Kumar Sur,&nbsp;Avijit Hazra,&nbsp;Alok Kumar Hazra,&nbsp;Dipankar Bhattacharyya","doi":"10.4103/0976-0105.183262","DOIUrl":"https://doi.org/10.4103/0976-0105.183262","url":null,"abstract":"<p><strong>Background: </strong>Bruguiera gymnorrhiza L. (family Rhizophoraceae) is a true mangrove habitat in Indian Sunderban and traditionally uses for liver disorders.</p><p><strong>Objectives: </strong>The aim was to evaluate antioxidant and hepatoprotective actions of leave extract of B. gymnorrhiza L.</p><p><strong>Materials and methods: </strong>Hydro-methanolic extract of mangrove leaves (BR) was standardized using spectrophotometric and high-performance thin layer chromatography methods. Radical scavenging activities were assessed in different in vitro methods, like 1,1-diphenyl-2-picrylhydrazyl, 2,2'-azino-bis-3-ethyl benzthiazoline-6-sulphonic acid (+), superoxides, nitric oxides and hydroxyl radicals. Hepatoprotective efficacy of BR (125 mg/kg and 250 mg/kg, p.o) was measured in D-galactosamine (GalN) induced (200 mg/kg, i.p) hepatitis in Wistar rats. Silymarin (25 mg/kg, p.o) was used as known hepatoprotective agent.</p><p><strong>Results: </strong>Polyphenols such as gallic acid, quercetin, and coumarin obtained from BR exhibited powerful antioxidant properties. Moreover, it produced dose-dependent protection against GalN induced hepatitis in rats. It significantly reduced GalN induced elevation of enzymes (alanine transaminase, aspartate aminotransferase, and alkaline phosphatase) in serum and resist oxidative stress marked by lipid peroxides, glutathione, and catalase in hepatic parenchyma.</p><p><strong>Conclusions: </strong>Polyphenols rich B. gymnorrhiza L. leaves ameliorate hepatic tissue injury through its antioxidant effects.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"7 3","pages":"75-9"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.183262","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34501950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates. 姜黄素与抗生素对产生生物膜的临床细菌分离株的抗菌协同作用。
Pub Date : 2016-06-01 DOI: 10.4103/0976-0105.183265
Arunava Kali, Devaraj Bhuvaneshwar, Pravin M V Charles, Kunigal Srinivasaiah Seetha

Introduction: The role of natural bioactive substances in treating infections has been rediscovered as bacterial resistance become common to most of the antibiotics. Curcumin is a bioactive substance from turmeric. Owing to antimicrobial properties, its prospect as an antibacterial agent is currently under focus.

Materials and methods: We have evaluated the in vitro synergy of curcumin with antibiotics against sixty biofilm producing bacterial isolates. Congo red agar method was used to identify the biofilm producing isolates. Curcumin minimum inhibitory concentration (MIC) was determined by agar dilution method. Its antibiotic synergy was identified by the increase in disc diffusion zone size on Mueller-Hinton agar with 32 mg/L curcumin.

Results: The mean MICs of curcumin against Gram-positive and Gram-negative isolates were 126.9 mg/L and 117.4 mg/L, respectively. Maximum synergy was observed with ciprofloxacin among Gram-positive and amikacin, gentamicin, and cefepime among Gram-negative isolates.

Conclusions: Curcumin per se as well as in combination with other antibiotics has a demonstrable antibacterial action against biofilm producing bacterial isolates. It may have a beneficial role in supplementing antibiotic therapy.

导读:随着细菌耐药性在大多数抗生素中变得普遍,天然生物活性物质在治疗感染中的作用已被重新发现。姜黄素是姜黄中的一种生物活性物质。由于其抗菌性能,其作为一种抗菌剂的前景目前备受关注。材料与方法:研究了姜黄素与抗生素对60株产膜细菌的体外协同作用。采用刚果红琼脂法对产膜菌株进行鉴定。琼脂稀释法测定姜黄素最低抑制浓度(MIC)。在32 mg/L姜黄素的作用下,muller - hinton琼脂上的圆盘扩散区大小增加,从而确定了其抗生素协同作用。结果:姜黄素对革兰氏阳性株和革兰氏阴性株的平均mic分别为126.9 mg/L和117.4 mg/L。革兰氏阳性菌株与环丙沙星的协同作用最大,革兰氏阴性菌株与阿米卡星、庆大霉素和头孢吡肟的协同作用最大。结论:姜黄素本身以及与其他抗生素联合使用对产生物膜细菌分离株具有明显的抗菌作用。它可能对补充抗生素治疗有有益的作用。
{"title":"Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates.","authors":"Arunava Kali,&nbsp;Devaraj Bhuvaneshwar,&nbsp;Pravin M V Charles,&nbsp;Kunigal Srinivasaiah Seetha","doi":"10.4103/0976-0105.183265","DOIUrl":"https://doi.org/10.4103/0976-0105.183265","url":null,"abstract":"<p><strong>Introduction: </strong>The role of natural bioactive substances in treating infections has been rediscovered as bacterial resistance become common to most of the antibiotics. Curcumin is a bioactive substance from turmeric. Owing to antimicrobial properties, its prospect as an antibacterial agent is currently under focus.</p><p><strong>Materials and methods: </strong>We have evaluated the in vitro synergy of curcumin with antibiotics against sixty biofilm producing bacterial isolates. Congo red agar method was used to identify the biofilm producing isolates. Curcumin minimum inhibitory concentration (MIC) was determined by agar dilution method. Its antibiotic synergy was identified by the increase in disc diffusion zone size on Mueller-Hinton agar with 32 mg/L curcumin.</p><p><strong>Results: </strong>The mean MICs of curcumin against Gram-positive and Gram-negative isolates were 126.9 mg/L and 117.4 mg/L, respectively. Maximum synergy was observed with ciprofloxacin among Gram-positive and amikacin, gentamicin, and cefepime among Gram-negative isolates.</p><p><strong>Conclusions: </strong>Curcumin per se as well as in combination with other antibiotics has a demonstrable antibacterial action against biofilm producing bacterial isolates. It may have a beneficial role in supplementing antibiotic therapy.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"7 3","pages":"93-6"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.183265","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34501953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 79
Knowledge of healthcare professionals about medication errors in hospitals. 医疗保健专业人员对医院用药错误的了解。
Pub Date : 2016-06-01 DOI: 10.4103/0976-0105.183264
Mohamed M M Abdel-Latif

Context: Medication errors are the most common types of medical errors in hospitals and leading cause of morbidity and mortality among patients.

Aims: The aim of the present study was to assess the knowledge of healthcare professionals about medication errors in hospitals.

Settings and design: A self-administered questionnaire was distributed to randomly selected healthcare professionals in eight hospitals in Madinah, Saudi Arabia.

Subjects and methods: An 18-item survey was designed and comprised questions on demographic data, knowledge of medication errors, availability of reporting systems in hospitals, attitudes toward error reporting, causes of medication errors.

Statistical analysis used: Data were analyzed with Statistical Package for the Social Sciences software Version 17.

Results: A total of 323 of healthcare professionals completed the questionnaire with 64.6% response rate of 138 (42.72%) physicians, 34 (10.53%) pharmacists, and 151 (46.75%) nurses. A majority of the participants had a good knowledge about medication errors concept and their dangers on patients. Only 68.7% of them were aware of reporting systems in hospitals. Healthcare professionals revealed that there was no clear mechanism available for reporting of errors in most hospitals. Prescribing (46.5%) and administration (29%) errors were the main causes of errors. The most frequently encountered medication errors were anti-hypertensives, antidiabetics, antibiotics, digoxin, and insulin.

Conclusions: This study revealed differences in the awareness among healthcare professionals toward medication errors in hospitals. The poor knowledge about medication errors emphasized the urgent necessity to adopt appropriate measures to raise awareness about medication errors in Saudi hospitals.

背景:用药错误是医院最常见的医疗错误类型,也是患者发病和死亡的主要原因。目的:本研究的目的是评估医疗保健专业人员对医院用药错误的认识。环境和设计:向沙特阿拉伯麦地那八家医院随机选择的保健专业人员分发了一份自我填写的问卷。对象和方法:设计了一项18项调查,包括人口统计数据、对用药错误的认识、医院报告系统的可用性、对用药错误报告的态度、用药错误的原因。使用的统计分析:使用Statistical Package for Social Sciences软件Version 17对数据进行分析。结果:共有323名医护人员完成问卷,其中医生138人(42.72%),药师34人(10.53%),护士151人(46.75%),回复率为64.6%。大多数参与者对用药错误的概念及其对患者的危害有很好的了解。只有68.7%的人了解医院的报告制度。医疗保健专业人员透露,大多数医院没有明确的错误报告机制。处方错误(46.5%)和给药错误(29%)是导致错误的主要原因。最常见的用药错误是抗高血压药、抗糖尿病药、抗生素、地高辛和胰岛素。结论:本研究揭示了医护人员对医院用药差错认知的差异。由于对用药错误缺乏了解,因此迫切需要采取适当措施,提高人们对沙特医院用药错误的认识。
{"title":"Knowledge of healthcare professionals about medication errors in hospitals.","authors":"Mohamed M M Abdel-Latif","doi":"10.4103/0976-0105.183264","DOIUrl":"https://doi.org/10.4103/0976-0105.183264","url":null,"abstract":"<p><strong>Context: </strong>Medication errors are the most common types of medical errors in hospitals and leading cause of morbidity and mortality among patients.</p><p><strong>Aims: </strong>The aim of the present study was to assess the knowledge of healthcare professionals about medication errors in hospitals.</p><p><strong>Settings and design: </strong>A self-administered questionnaire was distributed to randomly selected healthcare professionals in eight hospitals in Madinah, Saudi Arabia.</p><p><strong>Subjects and methods: </strong>An 18-item survey was designed and comprised questions on demographic data, knowledge of medication errors, availability of reporting systems in hospitals, attitudes toward error reporting, causes of medication errors.</p><p><strong>Statistical analysis used: </strong>Data were analyzed with Statistical Package for the Social Sciences software Version 17.</p><p><strong>Results: </strong>A total of 323 of healthcare professionals completed the questionnaire with 64.6% response rate of 138 (42.72%) physicians, 34 (10.53%) pharmacists, and 151 (46.75%) nurses. A majority of the participants had a good knowledge about medication errors concept and their dangers on patients. Only 68.7% of them were aware of reporting systems in hospitals. Healthcare professionals revealed that there was no clear mechanism available for reporting of errors in most hospitals. Prescribing (46.5%) and administration (29%) errors were the main causes of errors. The most frequently encountered medication errors were anti-hypertensives, antidiabetics, antibiotics, digoxin, and insulin.</p><p><strong>Conclusions: </strong>This study revealed differences in the awareness among healthcare professionals toward medication errors in hospitals. The poor knowledge about medication errors emphasized the urgent necessity to adopt appropriate measures to raise awareness about medication errors in Saudi hospitals.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"7 3","pages":"87-92"},"PeriodicalIF":0.0,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.183264","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34501952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 44
期刊
Journal of Basic and Clinical Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1